Toggle navigation
Our company
Overview
Leadership
Scientific Advisory Board
Board of Directors
Investors
Technology
Autologous
ex-vivo
gene therapy
The scientific advantage
R&D programmes
Overview
ADA-SCID
X-CGD
MPS-IIIA
MPS-IIIB
Follow-on programmes
News
2018
2017
Join us
Contact us
Latest news
Orchard Therapeutics announces the opening of US operations in Foster City, California